398 results
424B5
WINT
Windtree Therapeutics, Inc.
3 Sep 24
Prospectus supplement for primary offering
9:10am
stock under our stock incentive programs.
Any additional capital raised through the sale of equity or equity-backed securities may dilute our
424B5
WINT
Windtree Therapeutics, Inc.
3 Sep 24
Prospectus supplement for primary offering
9:09am
of our common stock reserved for future issuance under our Amended and Restated Windtree Therapeutics 2020 Equity Incentive Plan, or A&R 2020 Plan … .
In addition, shares of our common stock issuable upon exercise or vesting of incentive awards under our incentive plans are, once issued, eligible
8-K
EX-3.1
xbcdexk8t yf91i53
22 Jul 24
Entry into a Material Definitive Agreement
9:25am
8-K
EX-10.1
7riff fv3fx0
1 Jul 24
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-99.1
gvtbogwq
17 Apr 24
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
7:30am
8-K
EX-3.1
xdtpqmyoq hm8sq8qwy5
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-2.1
yny 1ybn2xn
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm